Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)

This trial is a randomized study to evaluate the Bimatoprost Implant System used in combination with the SpyGlass IOL to Timolol Ophthalmic Solution in participants with mild to moderate open-angle glaucoma or ocular hypertension undergoing cataract surgery.

NCT Number	NCT07218783
Lead Sponsor	SpyGlass Pharma, Inc.
Conditions	Cataract, Glaucoma, Ocular Hypertension
Enrollment	400 participants
Start Date	2025-10-15
Primary Completion	2029-03-31 (estimated)
Study Completion	2031-03-31 (estimated)
Updated on ClinicalTrials.gov	2025-10-20